Skip to main content

Advertisement

Log in

Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study is to evaluate and compare sexual satisfaction with the use of three types of hormonal contraceptives.

Methods

We have evaluated the sexological profile of 23 patients, treated with a subdermal hormonal contraceptive containing 68 mg etonogestrel. We have compared this profile to that of other two groups of previously studied patients: one consisting of 26 women treated with a vaginal ring releasing 120 µg/day of etonogestrel and 15 µg/day of ethinylestradiol (EE) and one consisting of 25 women treated with an oral contraceptive containing 20 µg of EE and 150 µg of desogestrel. A further group of 25 women, not in treatment with any type of hormonal contraceptive, has been studied as control group. The Interviewer Rating of Sexual Function (IRSF) has been completed by the patients at the beginning of the study and after cycles of 3 and 6 months of contraceptive usage.

Results

All three types of hormonal contraceptives have increased positive indicators of patients’ sexual life (sexual interest and fantasies, of orgasm number and intensity and satisfaction) and decreased negative ones (anxiousness, discomfort).

Conclusions

Subdermal contraception is slower than both intravaginal and oral hormonal contraceptives in giving these effects, but is more effective after a cycle of 6 months of usage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Piccinino LJ, Mosher WD (1998) Trends in contraceptive use in the United States: 1982–1995. Fam Plann Perspect 30:4–10

    Article  CAS  PubMed  Google Scholar 

  2. Rosenberg MJ, Meyers A, Roy V (2000) Efficacy, cycle control and side effects of low and lower dose oral contraceptives: a randomized trial of 20 and 35 µg estrogen preparations. Contraception 60:321–329

    Article  Google Scholar 

  3. Bjarnadottir RI, Tuppurainem M, Killik SR (2002) Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinylestradiol. Am J Obstet Gynecol 186:389–395

    Article  CAS  PubMed  Google Scholar 

  4. Sabatini R (2004) NuvaRing and sexual comfort. Giorn Ital Ostet Ginecol 26:321–324

    Google Scholar 

  5. Bitzer J, Simon JA (2011) Current issues and available options in combined hormonal contraception. Contraception 84:342–356

    Article  CAS  PubMed  Google Scholar 

  6. Sanders SA, Graham CA, Bass JL, Bancroft J (2001) A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 64:51–58

    Article  CAS  PubMed  Google Scholar 

  7. Caruso S, Agnello C, Intelisano G, Farina M, DiMari L, Cianci A (2004) Sexual behavior of women taking low-dose oral contraceptive containing 15 µg ethinylestradiol/60 µg gestodene. Contraception 69:234–237

    Article  Google Scholar 

  8. Schnabel P, Mommers E, Marintcheva-Petrova M (2009) Bioequivalence and X-ray visibility of radiopaque etonogestrel implant and Implanon. Abstract presented at the 8th Congress of the European Society of Gynecology, Rome, pp 10–13

    Google Scholar 

  9. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt HJ et al (2010) Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82:243–249

    Article  PubMed  Google Scholar 

  10. Walling MR (2010) Nexplanon the next step to the contraceptive implant. Woman’s Health J Prim Care 2(3):113–114

  11. Mommers E, BlumGF Gent TG, Peters KP, Sørdal TS, Marintcheva-Petrova M (2012) Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol 207(5):388.e1–388.e6

    Article  CAS  Google Scholar 

  12. Wynn V, Adams PW, Folkard J, Secd M (1975) Tryptophan, depression and steroidal contraception. J Steroid Biochem 6:965–970

    Article  CAS  PubMed  Google Scholar 

  13. Trussell J, Westoff CF (1980) Contraceptive practice and trends in coital frequency. Fam Plann Prospect 12:246–249

    Article  CAS  Google Scholar 

  14. Oddens BJ (1999) Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 59:277–286

    Article  CAS  PubMed  Google Scholar 

  15. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM (1995) The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progesterone-only methods. Contraception 52:363–369

    Article  CAS  PubMed  Google Scholar 

  16. Caruso S, Iraci Sareri M, Agnello C, Romano M, Lo Presti L, Malandrino C, Cianci A (2011) Conventional versus estende-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol. J Sex Med 8:1478–1485

    Article  CAS  PubMed  Google Scholar 

  17. Guida M, Di SpiezioSardo A, Bramante S, Sparice S, Acunzo G, Tommaselli GA, Di Carlo C, Pellicano M, Greco E, Nappi C (2005) Effects of two types of hormonal contraception -oral versus intravaginal- on the sexual life of women and their partners. Hum Reprod 20(4):1100–1106

    Article  CAS  PubMed  Google Scholar 

  18. Bancroft J, Tyrer G, Warnwr P (1982) The assessment of sexual problems in women. Br J Sex Med 9:30–37

    Google Scholar 

  19. Tyrer G, Steel JM, Ewing DJ, Bancroft J, Warner P, Clark BF (1983) Sexual responsiveness in diabetic women. Diabetologia 24:166–171

    Article  CAS  PubMed  Google Scholar 

  20. Gibbs N (2011) Love, sex, freedom and the paradox of the pill: a brief history of birth control, Kindle Edition. Time Inc., New York

  21. Williams Sanithia L, Parisi Sara M, Rachel Hess E, Schwarz Bimla (2012) Associations between recent contraceptive use and quality of life among women. Contraception 85(3):282–287

    Article  PubMed Central  PubMed  Google Scholar 

  22. Burrows Lara J, Basha Maureen, Goldstein Andrew T (2012) The Effects of Hormonal Contraceptives on Female Sexuality: A Review. J sex Med 9–9:2213–2223

    Article  Google Scholar 

  23. Bancroft J (1988) Sexual desire and the brain. Sex Marital Ther 3:11–27

    Article  Google Scholar 

  24. Basson R, Berman J, Burnet A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E et al (2000) Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 163:888–893

    Article  CAS  PubMed  Google Scholar 

  25. Walton B, Trashawn T (2003) Femal sexual dysfunction. Curr Women’s Health Report 3:319–326

    Google Scholar 

  26. Guida M, Visconti F, Cibarelli F, Granozio G, Troisi J, Martini E, Nappi R (2014) Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithm. Gynecol Endoc. doi:10.3109/09513590.2014.899348

    Google Scholar 

  27. Masters and Johnson (1987) On sex and human loving. Little, Brown

  28. Egarter C, Topcuoglu MA, Imhof M, Huber J (1999) Low dose oral contraceptives and quality of life. Contraception 59:287–291

    Article  CAS  PubMed  Google Scholar 

  29. Battaglia C, Battaglia B, Mancini F, Busacchi P, Paganotto MC, Morotti E, Venturoli S (2012) Sexual behavior and oral contraception: a pilot study. J Sex Med 9:550–557

    Article  CAS  PubMed  Google Scholar 

  30. Coenen CMH, Thomas CMG, Borm GF, Hollanders JMG, Rollando R (1996) Changes in androgens during treatment with four low-dose contraceptives. Contraception 53:171–176

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessandra Gallo.

Additional information

All authors have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guida, M., Cibarelli, F., Troisi, J. et al. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration. Arch Gynecol Obstet 290, 1239–1247 (2014). https://doi.org/10.1007/s00404-014-3323-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3323-4

Keywords

Navigation